AMD Publications

Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

Ophthalmology Retina

, (epub)

2022 May

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

Eye

, (epub)

2022 May

Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

Clinical and Experimental Ophthalmology

2022 April

International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry

Retina

2022 April

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry

Acta Ophthalmology

, (epub)

2022 March

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration

Retina

, (epub)

2022 February

Quality of life impact of eye diseases: a Save Sight Registries study

Clinical and Experimental Ophthalmology

, (epub)

2022 January

The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration

Retina

2022 January

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

Transl Vis Sci Technol

2021 November

Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence

Eye

2021 October

Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands

Acta Ophthalmologica

2021 September

Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater

Clinical and Experimental Ophthalmology

2021 August

Email: ssi.ssr@sydney.edu.au
Phone: (+61) 421 787 808

Level 1, South Block
Sydney Eye Hospital
8 Macquarie Street
Sydney NSW 2000

AMD Publications

Incidence, Risk Factors and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor for Retinal Diseases: Data from the Fight Retinal Blindness! Registry

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes

International impact of the COVID-19 pandemic lockdown on intravitreal therapy outcomes: Fight Retinal Blindness registry

Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry

Longer treatment intervals are associated with reduced treatment persistence in neovascular age related macular degeneration

Quality of life impact of eye diseases: a Save Sight Registries study

The impact of disease activity on 5-year outcomes in patients undergoing treatment for neovascular age-related macular degeneration

Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

Extended intervals for wet AMD patients with high retreatment needs: informing the risk during COVID-19, data from real-world evidence

Real-world treatment outcomes of neovascular Age-related Macular Degeneration in the Netherlands

Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greater

Follow us

Quick links